TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.
Saved in:
| Title: | TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target. |
|---|---|
| Authors: | Kennedy E; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom., Coulter E; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Halliwell E; UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Profitos-Peleja N; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Walsby E; Cardiff CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom., Clark B; Molecular Pathology Laboratory, King's College Hospital, London, United Kingdom., Phillips EH; Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Burley TA; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom., Mitchell S; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom., Devereux S; Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Fegan CD; Cardiff CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom., Jones CI; Department of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer, United Kingdom., Johnston R; Department of Haematology, Brighton and Sussex University Hospital Trust, Brighton, United Kingdom., Chevassut T; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.; Department of Haematology, Brighton and Sussex University Hospital Trust, Brighton, United Kingdom., Schulz R; German Cancer Research Centre (DKFZ), Heidelberg, Germany., Seiffert M; German Cancer Research Centre (DKFZ), Heidelberg, Germany., Agathanggelou A; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and., Oldreive C; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and., Davies N; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and., Stankovic T; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and., Liloglou T; Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom., Pepper C; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom., Pepper AGS; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom. |
| Source: | Blood [Blood] 2021 Jun 03; Vol. 137 (22), pp. 3064-3078. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33512408 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kennedy+E%22">Kennedy E</searchLink>; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Coulter+E%22">Coulter E</searchLink>; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Halliwell+E%22">Halliwell E</searchLink>; UCL Great Ormond Street Institute of Child Health, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Profitos-Peleja+N%22">Profitos-Peleja N</searchLink>; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Walsby+E%22">Walsby E</searchLink>; Cardiff CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Clark+B%22">Clark B</searchLink>; Molecular Pathology Laboratory, King's College Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Phillips+EH%22">Phillips EH</searchLink>; Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Burley+TA%22">Burley TA</searchLink>; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mitchell+S%22">Mitchell S</searchLink>; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Devereux+S%22">Devereux S</searchLink>; Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Fegan+CD%22">Fegan CD</searchLink>; Cardiff CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jones+CI%22">Jones CI</searchLink>; Department of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Johnston+R%22">Johnston R</searchLink>; Department of Haematology, Brighton and Sussex University Hospital Trust, Brighton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Chevassut+T%22">Chevassut T</searchLink>; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.; Department of Haematology, Brighton and Sussex University Hospital Trust, Brighton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Schulz+R%22">Schulz R</searchLink>; German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Seiffert+M%22">Seiffert M</searchLink>; German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Agathanggelou+A%22">Agathanggelou A</searchLink>; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and.<br /><searchLink fieldCode="AU" term="%22Oldreive+C%22">Oldreive C</searchLink>; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and.<br /><searchLink fieldCode="AU" term="%22Davies+N%22">Davies N</searchLink>; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and.<br /><searchLink fieldCode="AU" term="%22Stankovic+T%22">Stankovic T</searchLink>; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and.<br /><searchLink fieldCode="AU" term="%22Liloglou+T%22">Liloglou T</searchLink>; Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pepper+C%22">Pepper C</searchLink>; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pepper+AGS%22">Pepper AGS</searchLink>; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2021 Jun 03; Vol. 137 (22), pp. 3064-3078. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33512408 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood.2020005964 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3064 Titles: – TitleFull: TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kennedy E – PersonEntity: Name: NameFull: Coulter E – PersonEntity: Name: NameFull: Halliwell E – PersonEntity: Name: NameFull: Profitos-Peleja N – PersonEntity: Name: NameFull: Walsby E – PersonEntity: Name: NameFull: Clark B – PersonEntity: Name: NameFull: Phillips EH – PersonEntity: Name: NameFull: Burley TA – PersonEntity: Name: NameFull: Mitchell S – PersonEntity: Name: NameFull: Devereux S – PersonEntity: Name: NameFull: Fegan CD – PersonEntity: Name: NameFull: Jones CI – PersonEntity: Name: NameFull: Johnston R – PersonEntity: Name: NameFull: Chevassut T – PersonEntity: Name: NameFull: Schulz R – PersonEntity: Name: NameFull: Seiffert M – PersonEntity: Name: NameFull: Agathanggelou A – PersonEntity: Name: NameFull: Oldreive C – PersonEntity: Name: NameFull: Davies N – PersonEntity: Name: NameFull: Stankovic T – PersonEntity: Name: NameFull: Liloglou T – PersonEntity: Name: NameFull: Pepper C – PersonEntity: Name: NameFull: Pepper AGS IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 06 Text: 2021 Jun 03 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1528-0020 Numbering: – Type: volume Value: 137 – Type: issue Value: 22 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |